The same in other media
Covid-19 pandemic: the hype around anti-malarial hydroxychloroquine
Reading now: 638
Hydroxychloroquine has attracted significant news coverage over the past two weeks as a potential treatment for Covid-19, which, at the time of writing, has caused more than 120,000 deaths globally.
Approved to treat malaria and lupus, hydroxychloroquine has been heralded by US President Donald Trump as a very promising drug to fight Covid-19 or what he calls the ‘invisible enemy’ during his press briefings over the 4 and 5 April.
He stated: “What do you have to lose? Take it.” However, Trump did acknowledge that he is: “Not a doctor,” and advised people to talk to their doctors about the medication.
In the 5 April briefing, President Trump claimed the US Food and Drug Administration (FDA) had approved the drug. However, the regulator is
Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
